These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2478195)
1. Calcium-dependent polymerization of human serum amyloid P component is inhibited by heparin and dextran sulfate. Hamazaki H Biochim Biophys Acta; 1989 Oct; 998(3):231-5. PubMed ID: 2478195 [TBL] [Abstract][Full Text] [Related]
2. Ca2+-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate. Hamazaki H J Biol Chem; 1987 Feb; 262(4):1456-60. PubMed ID: 2948956 [TBL] [Abstract][Full Text] [Related]
3. Calcium-enhanced aggregation of serum amyloid P component and its inhibition by the ligands heparin and heparan sulphate. An electron microscopic and immunoelectrophoretic study. Nielsen EH; Sørensen IJ; Vilsgaard K; Andersen O; Svehag SE APMIS; 1994 Jun; 102(6):420-6. PubMed ID: 8068301 [TBL] [Abstract][Full Text] [Related]
4. Binding of serum amyloid P component to heparin in human serum. Li XA; Hatanaka K; Guo L; Kitamura Y; Yamamoto A Biochim Biophys Acta; 1994 Nov; 1201(2):143-8. PubMed ID: 7947925 [TBL] [Abstract][Full Text] [Related]
5. Heparin influence on the complex of serum amyloid P component and complement C4b-binding protein. Schwalbe RA; Dahlbäck B; Nelsestuen GL J Biol Chem; 1991 Jul; 266(20):12896-901. PubMed ID: 2071579 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Baba M; Pauwels R; Balzarini J; Arnout J; Desmyter J; De Clercq E Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6132-6. PubMed ID: 2457906 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of fibrin polymerization by serum amyloid P component and heparin. Meyer K; Smith R; Williams EC Thromb Haemost; 1987 Jun; 57(3):345-8. PubMed ID: 3660334 [TBL] [Abstract][Full Text] [Related]
8. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. Lederman S; Gulick R; Chess L J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782 [TBL] [Abstract][Full Text] [Related]
9. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins. Williams EC; Huppert BJ; Asakura S J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216 [TBL] [Abstract][Full Text] [Related]
10. Calcium-dependent and -independent binding of the pentraxin serum amyloid P component to glycosaminoglycans and amyloid proteins: enhanced binding at slightly acid pH. Danielsen B; Sørensen IJ; Nybo M; Nielsen EH; Kaplan B; Svehag SE Biochim Biophys Acta; 1997 Apr; 1339(1):73-8. PubMed ID: 9165101 [TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Matzner Y; Marx G; Drexler R; Eldor A Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320 [TBL] [Abstract][Full Text] [Related]
12. The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion. Silverberg M; Diehl SV Biochem J; 1987 Dec; 248(3):715-20. PubMed ID: 2449171 [TBL] [Abstract][Full Text] [Related]
13. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation. García de Frutos P; Dahlbäck B J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054 [TBL] [Abstract][Full Text] [Related]
14. Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G. Ledoux D; Merciris D; Barritault D; Caruelle JP FEBS Lett; 2003 Feb; 537(1-3):23-9. PubMed ID: 12606025 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of factor VIII-associated platelet aggregation by heparin and dextran sulfate, and its mechanism. Suzuki K; Nishioka J; Hashimoto S Biochim Biophys Acta; 1979 Jul; 585(3):416-26. PubMed ID: 486540 [TBL] [Abstract][Full Text] [Related]
16. Time-dependent conformational change of thrombin molecules induced by sulfated polysaccharides. Oshima G Chem Pharm Bull (Tokyo); 1989 May; 37(5):1324-8. PubMed ID: 2483535 [TBL] [Abstract][Full Text] [Related]
17. Polysaccharides with sulfate groups are human T cell mitogens and murine polyclonal B cell activators (PBAs) II. Cellulose sulfate and dextran sulfate with two different lower molecular weights. Sugawara I; Ishizaka S Microbiol Immunol; 1984; 28(7):831-9. PubMed ID: 6208459 [TBL] [Abstract][Full Text] [Related]
18. Specificity of sulfated polysaccharides to accelerate the inhibition of activated protein C by protein C inhibitor. Kazama Y; Niwa M; Yamagishi R; Takahashi K; Sakuragawa N; Koide T Thromb Res; 1987 Oct; 48(2):179-85. PubMed ID: 2447665 [TBL] [Abstract][Full Text] [Related]
19. The effect of sulfated polysaccharides on the free intracellular calcium ion concentration of lymphocytes. Tellam RL; Parish CR Biochim Biophys Acta; 1987 Aug; 930(1):55-64. PubMed ID: 2441758 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Ito M; Baba M; Sato A; Pauwels R; De Clercq E; Shigeta S Antiviral Res; 1987 Jul; 7(6):361-7. PubMed ID: 2445284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]